Rep. Tim Moore Buys Centene Corporation (NYSE:CNC) Stock

Rep. Tim Moore Buys Centene Corporation (NYSE:CNC) Stock

Representative Tim Moore (Republican) disclosed the purchase of $15,001 - $50,000 of Centene Corporation (NYSE:CNC) stock in a filing made on August 06th, 2025. The transaction, dated July 18th, 2025, was reported on his congressional financial disclosure.

Tim Moore's Recent Trades

• 2/18/2026: Sold $1,001 - $15,000 of COIN stock
• 2/12/2026: Bought $1,001 - $15,000 of DNUT stock
• 2/11/2026: Bought $15,001 - $50,000 of SIMPLY GOOD FOODS COMPANY stock
• 2/5/2026: Bought $1,001 - $15,000 of GNPX stock
• 2/3/2026: Bought $15,001 - $50,000 of SIMPLY GOOD FOODS COMPANY stock
• 1/30/2026: Sold $15,001 - $50,000 of VZ stock
• 1/30/2026: Sold $15,001 - $50,000 of T stock
• 1/23/2026: Bought $15,001 - $50,000 of HOG stock
• 1/9/2026: Bought $15,001 - $50,000 of T stock
• 1/5/2026: Sold $50,001 - $100,000 of CBRL stock

CNC Stock Performance

Shares of CNC opened at $44.16 on Wednesday, up 2.67%. The 50-day moving average is $42.83 and the 200-day moving average is $39.25. The 52-week low is $25.08 and the 52-week high is $66.03.

Since the transaction date (July 18th, 2025), CNC shares have risen 54.76%, opening at $29.07 on the transaction date. The stock fell 2.34% in the first week and fell 10.87% over two weeks, and fell 0.28% over one month.

Centene's debt-to-equity ratio is 0.94, the current ratio is 1.68 and the quick ratio is 1.68. Market capitalization is $22.12 billion, the trailing P/E is -3.31 and beta is 0.46. For fiscal 2025 the company reported revenue of $194.78 billion and net income of -$6.67 billion, with EPS of -13.61. Return on equity (TTM) is -27.74% and net profit margin (TTM) is -3.43%. Year-over-year revenue grew 19.45%. Analysts' full-year EPS average forecast is $8.27.

Key Stories Impacting CNC

• (Neutral) Feb 6, 2026 1: Centene reported 2025 results with a GAAP diluted loss per share $(13.53), adjusted diluted EPS of $2.08 for 2025, provided 2026 guidance of adjusted EPS greater than $3.00 and disclosed a definitive agreement to divest remaining Magellan Health businesses.
• (Negative) Aug 1, 2025 1: A shareholder sued Centene's board alleging the company overhyped its 2025 profit outlook and then revoked guidance after a >40% one-day stock plunge.
• (Neutral) Feb 2026 1: Analyst commentary characterized 2025 as a transition year and said management is positioning for an earnings rebound in 2026 after marketplace pressure and higher medical costs in 2025.
• (Positive) Nov 2025 1: At the HLTH conference CEO Sarah London said ICHRA is the future of individual health insurance and noted plans to pilot/offer ICHRA to employees in certain states in 2026.
• (Neutral) Apr 25, 2025 1: Centene's CEO said there was "no broad support" in Washington for proposed Medicaid cuts, signaling the company's policy posture regarding Medicaid enrollment and reimbursement discussions.
• (Negative) Dec 2025 1: Centene recorded substantial non-cash impairment charges tied to the pending divestiture of its remaining Magellan Health businesses.

Analyst Ratings for CNC

Wells Fargo reiterated an 'Equal Weight' rating. Cantor Fitzgerald reiterated a 'Neutral' rating. Wells Fargo reiterated an 'Equal Weight' rating. Barclays upgraded to an 'Overweight' rating. Bernstein maintained an 'Outperform' rating.

Presently, 370 analysts have rated CNC with a buy recommendation, 211 have issued a hold, and 26 have given a sell rating. The average rating is 'Moderate Buy' with an average price target of $45.50.

Institutional Investors Weigh In On CNC

VANGUARD GROUP INC holds 56,978,753 shares worth $2,563,474,097. BLACKROCK, INC. holds 44,396,864 shares worth $1,997,414,911. AQR CAPITAL MANAGEMENT LLC holds 31,798,738 shares worth $1,430,625,223. STATE STREET CORP holds 21,423,835 shares worth $963,858,337. GEODE CAPITAL MANAGEMENT, LLC holds 13,271,492 shares worth $597,084,425. Currently, 96.65% of the stock is owned by institutional investors.

About Tim Moore

Representative Tim Moore is a Republican member of the U.S. House representing North Carolina's 14th congressional district. He was born in 1970 and is 56 years old. Moore has served in the House since 2025 and his official website is listed as timmoore.house.gov.

About CNC

Centene Corporation is a Medical - Healthcare Plans company that operates as a multi-national healthcare enterprise providing programs and services to under-insured and uninsured individuals in the United States. The company is headquartered in Saint Louis, Missouri, was founded in 1984 and completed its IPO in 2001. Key business lines include managed care plans, specialty services such as pharmacy benefits management, vision and dental services, and services to correctional systems.